Lentiviral vectors for the treatment of primary immunodeficiencies.
about
Clinical applications of gene therapy for primary immunodeficiencies.Overview of Immunodeficiency Disorders.Lentiviral Vector Gene Therapy Protects XCGD Mice From Acute Staphylococcus aureus Pneumonia and Inflammatory Response.A Simple High Efficiency Intra-Islet Transduction Protocol Using Lentiviral Vectors.Novel GP64 envelope variants for improved delivery to human airway epithelial cells.NADPH Oxidase Deficiency: A Multisystem Approach.Integrating HDAd5/35++ Vectors as a New Platform for HSC Gene Therapy of Hemoglobinopathies.
P2860
Q35539617-5B4F8320-3E7C-4183-B032-65D32DC2A07AQ38603706-2BBD3B52-C364-4C8E-BC69-D17E20B91CDFQ39561887-5269CF4B-A351-423D-9484-742F24D5EF92Q41630877-E8F0658B-C90E-4FFD-BD83-4F231784F00EQ45871641-DF8B61AA-383B-4FD8-9A79-AE11E503117BQ49422978-5060383E-15ED-4CD9-80E8-60D02303E52EQ55333613-4A4BCDD9-AA84-4E9A-BEF5-5EB3B5668A73
P2860
Lentiviral vectors for the treatment of primary immunodeficiencies.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Lentiviral vectors for the treatment of primary immunodeficiencies.
@en
type
label
Lentiviral vectors for the treatment of primary immunodeficiencies.
@en
prefLabel
Lentiviral vectors for the treatment of primary immunodeficiencies.
@en
P2093
P2860
P1476
Lentiviral vectors for the treatment of primary immunodeficiencies.
@en
P2093
Giada Farinelli
Samantha Scaramuzza
Valentina Capo
P2860
P2888
P304
P356
10.1007/S10545-014-9690-Y
P577
2014-03-12T00:00:00Z
P6179
1047895227